“Comparative Utility of Doxorubicin, Cyclophosphamide, and Docetaxel in Breast Cancer Treatment in West Sumatera”., Pharm.biomed.Sci.J, vol. 6, no. 2, pp. 152–160, Dec. 2024, doi: 10.15408/pbsj.v6i2.40914.